Mtalib baumannii acinetobacter 2

1,975 views

Published on

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,975
On SlideShare
0
From Embeds
0
Number of Embeds
48
Actions
Shares
0
Downloads
57
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Mtalib baumannii acinetobacter 2

  1. 1. Acinetobacter baumannii Maliha Talib MB 360 (Lee) Spring 2014
  2. 2. Origination •Traced back to Vietnam War •Recent outbreak during Iraq War •Original outbreak from Europe •>> 700 soldiers effected
  3. 3. General Information Taxonomic Classification: •Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; Acinetobacter Microbiologic Morphology: •gram negative •aerobic •cocco-bacillus •encapsulated •nonmotile •catalase-positive •oxidase-negative
  4. 4. General Information Catalase = positive The purpose is to see if the microbe has catalase or can destroy chemical hydrogen peroxide. Oxidase = negative Identifies organisms that produce the enzyme cytochrome oxidase.
  5. 5. General Information Habitat •soil, water, food, sewage, & the hospital environment •resistant to desiccation and disinfection •Survive on moist & dry surfaces •forms bio-film on catheters, ventilators, and other medical devices •Iraq/Afghanistan
  6. 6. General Information
  7. 7. General Information
  8. 8. General Information Nutrition •grows on various media •can live in hospital settings 9 days after patient leaves •Acinetobacter calcoaceticus-baumanii complex: glucose-oxidising nonhemolytic, •Acinetobacter lwoffii: glucose-negative nonhemolytic •Acinetobacter haemolyticus: haemolytic on blood agar.
  9. 9. Pathogenesis Diseases •Bloodstream infections: pneumonia, urinary tract infections, and septicemia •mostly respiratory >> can lead to death •32 species: cause of 80% of infections •nosocomial Examples of Major Infections •Ventilator-associated pneumonia •Urinary tract •Bloodstream infection •Secondary meningitis •Skin/wound infections •Endocarditis •CAPD-associated peritonitis •Ventriculitis
  10. 10. Pathogenesis
  11. 11. Pathogenesis
  12. 12. Pathogenesis Transmission •spread via person to person OR •contact with contaminated environment
  13. 13. Pathogenesis
  14. 14. Pathogenesis Transmission • • • • • • • • Bed rails Bedside tables Ventilators Infusion pumps Mattresses Pillows Air humidifiers Patient monitors • • • • • • • X-ray view boxes Curtain rails Curtains Equipment carts Sinks Ventilator circuits Floor mops
  15. 15. Pathogenesis Mechanisms •Aminoglycosides-modifying enzymes •Broad-spectrum β-lactamases •Carbapenemases •Quantitative and/or qualitative changes in outer membrane porins •Altered penicillin-binding proteins.
  16. 16. Pathogenesis Circular map of A. baumannii genome. Smith M G et al. Genes Dev. 2007;21:601-614 Copyright © 2007, Cold Spring Harbor Laboratory Press
  17. 17. Pathogenesis Symptoms •standard infection symptoms i.e. fever •death within 14 days of surgery Predisposed factors •Malignancy •Trauma •Burns •Surgical wound infections •Neonates •Low birth weight •Need for mechanical ventilation Diagnosis •clinical culture of blood, sputum, urine, wound, sterile body fluid, etc.
  18. 18. Factors leading to the emergence and transmission of multidrug-resistant (MDR) Acinetobacter species. Eliopoulos G M et al. Clin Infect Dis. 2008;46:12541263 © 2008 by the Infectious Diseases Society of America
  19. 19. Pathogenesis Treatment • Will collect: age, sex, occupation, hospital location at the time of positive culture (ER, medical ward, ICU etc), date of positive culture, prior hospitalization, receipt of outpatient dialysis, home care or other regular medical care (eg, outpatient chemotherapy), presence of invasive devices, receipt of antibiotics, etc. •Carbapenems (Imipenem and Meropenem) - growing resistance •Others: Polymyxin, Tigecycline and Aminoglycosides
  20. 20. Pathogenesis
  21. 21. Pathogenesis
  22. 22. Methods for control and prevention of multidrug-resistant Acinetobacter infection. Pathogenesis Prevention: •Wash hands •contact precautions •environmental decontamination
  23. 23. Antibiotic Resistance •naturally transformable •AcomFECB and comQLONM allow uptake of DNA from the environment •administration of subtheraputic doses of antimicrobial agents, drug overuse, interrupted courses of treatment, and poor tissue penetration by antimicrobial agent •Medical interventions increasing the Acinetobacter Infections
  24. 24. Antibiotic Resistance • Most A. baumannii resistant: tampicillin, Carbenicillin, Cefotaxime and Chloramphenicol. • Increasing resistance:Gentamycin, tobramycin and amikacin is increasing. • May retain: Fluoroquinolones, ceftazidime,TrimethoprimSulphmethoxazole, Doxycycline, Polymyxin B, colistin, imipenem and meropenem
  25. 25. Antibiotic Resistance "Acinetobacter baumannii membrane transporter PilQ allows initial entry of foreign DNA into the cell. Foreign DNA is then bound by protein ComE and is directed to cytoplasmic membrane transporter ComA."
  26. 26. Antibiotic Resistance Sent troops to Iraq Bush's increase of troops to protect Baghdad and Al Anbar Province
  27. 27. Cost of Outbreak
  28. 28. Works Cited •Federico Perez, Andrea M. Hujer, Kristine M. Hujer, BrookeK. Decker, Philip N. Rather and Robert A. Bonomo Antimicrob. Agents Chemother. 2007, 51(10):3471. DOI:10.1128/AAC.01464-06. Published Ahead of Print 23 July 2007. •George M. Eliopoulos, Lisa L. Maragakis, and Trish M. Perl Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options Clin Infect Dis. (2008) 46 (8): 1254-1263 doi:10.1086/529198 •Hujer, K. Hujer, A. Hulten, E. Bajaksouzian, S. Adams, J. Donskey, C. Ecker, D. Massire, C. Eshoo, M., Sampath, R., Thomson, J. Rather, P., Craft, D., Fishbain, J., Ewell, A., Jacobs, M. Paterson, D., Bonomo, R. “Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients treated at the Walter Reed Army Medical Center.” Antimicrboia Agents and Chemotherapy. Dec. 2006. Volume. 50, No. 12. 4114-4123. •José M. Cisneros, Maria J. Reyes, Jerónimo Pachón, Berta Becerril, Francisco J. Caballero, José L. García Garmendia, Carlos Ortiz, and Adelaido R. Cobacho Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic Features Clin Infect Dis. (1996) 22 (6): 1026-1032 doi:10.1093/clinids/22.6.1026 •Lenie Dijkshoorn, Alexandr Nemec & Harald Seifert An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nature Reviews Microbiology 5, 939-951 (December 2007) doi:10.1038/nrmicro1789 •Mortensen, B. L. and Skaar, E. P. (2012), Host–microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cellular Microbiology, 14: 1336–1344. doi: 10.1111/j.1462-5822.2012.01817.x

×